Mirum Pharmaceuticals, Inc.

By person

34 insiders · 214 transactions

74.1×

Christopher Peetz holds 74.1 times base salary in stock. $56.02M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Peetz last reported holding, valued at $98.37, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Peetz Christopher

CHIEF EXECUTIVE OFFICER

$294.22K (6)

$25.77M (32) scheduled

−$25.48M

569,440

0.8770%

$56.02M

+51.7%

Heron Patrick J

Director

$20.35M (19)

—

+$20.35M

464,713

0.7157%

$45.71M

—

GREY MICHAEL G

Director

—

$12.40M (7) scheduled

−$12.40M

186,410

0.2871%

$18.34M

−33.7%

Howe Jolanda

SVP, GLOBAL CONTROLLER

—

$9.33M (27) scheduled

−$9.33M

616

0.0009%

$60.60K

−65.2%

Novo Holdings A/S entity

10% owner

$8.63M (1)

—

+$8.63M

2,445,147

3.77%

$240.53M

—

BARRIS PETER J

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$411.80M

—

BASKETT FOREST

10% owner

$6.75M (1)

—

+$6.75M

1,548

0.0024%

$152.28K

—

Behbahani Ali

10% owner

$6.75M (1)

—

+$6.75M

135

0.0002%

$13.28K

—

Chang Carmen

10% owner

$6.75M (1)

—

+$6.75M

135

0.0002%

$13.28K

—

Florence Anthony A. Jr.

10% owner

$6.75M (1)

—

+$6.75M

11,732

0.0181%

$1.15M

—

Frazier Life Sciences IX, L.P.

10% owner

$6.75M (1)

—

+$6.75M

3,566,912

5.49%

$350.88M

—

Makhzoumi Mohamad

10% owner

$6.75M (1)

—

+$6.75M

11,348

0.0175%

$1.12M

—

MAKOWER JOSHUA

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$411.80M

—

MOTT DAVID M

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$411.80M

—

New Enterprise Associates 16, L.P. entity

10% owner

$6.75M (1)

—

+$6.75M

2,186,243

3.37%

$215.06M

—

SANDELL SCOTT D

10% owner

$6.75M (1)

—

+$6.75M

11,348

0.0175%

$1.12M

—

Sonsini Peter W.

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$411.80M

—

Walker Paul Edward

10% owner

$6.75M (1)

—

+$6.75M

114

0.0002%

$11.21K

—

Radovich Peter

PRESIDENT AND COO

—

$3.99M (16)

−$3.99M

57,260

0.0882%

$5.63M

+1,897%

BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

$397.69K (3)

$4.29M (14)

−$3.89M

44,745

0.0689%

$4.40M

+5,996%

Ramasastry Saira

Director

—

$2.42M (13) scheduled

−$2.42M

0.0000%

$0.00

—

Quan Joanne

CHIEF MEDICAL OFFICER

—

$1.78M (4)

−$1.78M

18,864

0.0291%

$1.86M

+28,055%

O'Donnell Niall

Director

$4.50M (1)

$5.96M (3)

−$1.46M

1,621,118

2.50%

$159.47M

+1,197%

Flynn James E

10% owner

$4.98M (2)

$3.62M (10)

+$1.36M

1,540,190

2.37%

$151.51M

—

Vig Pamela

CHIEF SCIENTIFIC OFFICER

$17.68K (2)

$1.20M (6) scheduled

−$1.18M

27,406

0.0422%

$2.70M

—

Brege Laura

Director

$112.20K (1)

$1.26M (2) scheduled

−$1.15M

15,703

0.0242%

$1.54M

—

Fairey William

Director

—

$155.09K (1)

−$155.09K

2,500

0.0039%

$245.93K

—

Longpre Lara

CHIEF DEVELOPMENT OFFICER

$10.27K (1)

$115.69K (5)

−$105.42K

104,407

0.1608%

$10.27M

+39.1%

Clements Ian

Chief Financial Officer

$112.52K (6)

$30.31K (1)

+$82.21K

30,011

0.0462%

$2.95M

+99,937%

Fischer Laurent

Director

$69.02K (6)

—

+$69.02K

10,727

0.0165%

$1.06M

—

Tucker Edwin Jonathan

Chief Medical Officer

$49.56K (2)

$26.26K (1)

+$23.29K

45,838

0.0706%

$4.51M

+2,956%

NEA Partners 16, L.P. entity

10% owner

—

2,186,243

3.37%

$215.06M

−47.8%

Walbert Timothy P

Director

—

9,680

0.0149%

$952.22K

—

Cardon Lon

Director

—

9,680

0.0149%

$952.22K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Peetz Christopher

1 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

21,688

$98.91

$2.15M

Peetz Christopher

1 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

8,312

$98.08

$815.24K

Howe Jolanda

18 Aug 2026

SVP, GLOBAL CONTROLLER

Sold after exercise

40,000

$100.00

$4.00M

Peetz Christopher

10 Aug 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

2,300

$100.14

$230.32K

Peetz Christopher

10 Aug 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

6,017

$99.25

$597.19K

Peetz Christopher

10 Aug 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

11,683

$98.51

$1.15M

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,710

$124.79

$213.39K

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,975

$123.74

$244.39K

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

4,181

$122.34

$511.50K

Peetz Christopher

6 Jul 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

12,134

$121.65

$1.48M

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

883

$99.66

$88.00K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,021

$98.20

$100.26K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

1,973

$97.56

$192.49K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

6,926

$96.15

$665.93K

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

16,595

$95.34

$1.58M

Peetz Christopher

1 Jun 2026

CHIEF EXECUTIVE OFFICER

Sold after exercise

2,602

$94.64

$246.25K

Ramasastry Saira

15 May 2026

Director

Sold after exercise

2,000

$109.47

$218.94K

Ramasastry Saira

15 Apr 2026

Director

Sold after exercise

2,000

$96.90

$193.80K

Ramasastry Saira

16 Mar 2026

Director

Sold after exercise

2,000

$90.76

$181.52K

Ramasastry Saira

13 Feb 2026

Director

Sold after exercise

2,000

$102.09

$204.18K

Ramasastry Saira

15 Jan 2026

Director

Sold after exercise

2,000

$90.99

$181.98K

Ramasastry Saira

22 Dec 2025

Director

Sold after exercise

5,000

$80.00

$400.00K

GREY MICHAEL G

19 Dec 2025

Director

Sold after exercise

50,000

$78.00

$3.90M

Ramasastry Saira

18 Dec 2025

Director

Sold after exercise

1,000

$70.00

$70.00K

Ramasastry Saira

18 Dec 2025

Director

Sold after exercise

1,000

$69.46

$69.46K

GREY MICHAEL G

1 Dec 2025

Director

Sold after exercise

50,000

$74.00

$3.70M

GREY MICHAEL G

21 Nov 2025

Director

Sold after exercise

50,000

$70.00

$3.50M

Brege Laura

11 Sep 2025

Director

Sold after exercise

1,491

$75.07

$111.93K

Brege Laura

11 Sep 2025

Director

Sold after exercise

15,509

$74.34

$1.15M

Ramasastry Saira

8 Sep 2025

Director

Sold after exercise

17,000

—

no price

Peetz Christopher

11 Aug 2025

CHIEF EXECUTIVE OFFICER

Sold after exercise

40,000

$62.00

$2.48M

Peetz Christopher

7 Aug 2025

CHIEF EXECUTIVE OFFICER

Sold after exercise

40,000

$55.25

$2.21M

Howe Jolanda

7 Aug 2025

SVP, GLOBAL CONTROLLER

Sold after exercise

10,000

$58.00

$580.00K

Ramasastry Saira

3 Jun 2025

Director

Sold after exercise

2,500

$45.74

$114.35K

Howe Jolanda

17 Mar 2025

SVP, GLOBAL CONTROLLER

Sold after exercise

1,806

$44.36

$80.11K

Howe Jolanda

17 Mar 2025

SVP, GLOBAL CONTROLLER

Sold after exercise

2,789

$44.75

$124.80K

Howe Jolanda

17 Mar 2025

SVP, GLOBAL CONTROLLER

Sold after exercise

50,111

$44.33

$2.22M

Howe Jolanda

17 Mar 2025

SVP, GLOBAL CONTROLLER

Sold after exercise

2,900

$44.21

$128.22K

Peetz Christopher

3 Mar 2025

CHIEF EXECUTIVE OFFICER

Sold after exercise

20,608

$47.19

$972.49K

Peetz Christopher

3 Mar 2025

CHIEF EXECUTIVE OFFICER

Sold after exercise

19,392

$46.61

$903.86K

Howe Jolanda

14 Nov 2024

SVP, GLOBAL CONTROLLER

Sold after exercise

2,500

$47.10

$117.75K

Vig Pamela

24 Jun 2024

CHIEF SCIENTIFIC OFFICER

Sold after exercise

30,559

$34.00

$1.04M

Ramasastry Saira

5 Jun 2024

Director

Sold after exercise

5,000

$25.68

$128.40K

Howe Jolanda

5 Dec 2023

SVP, Global Controller

Sold after exercise

2,500

$32.40

$81.00K

GREY MICHAEL G

14 Sep 2023

Director

Sold after exercise

14,216

$32.00

$454.91K

GREY MICHAEL G

13 Sep 2023

Director

Sold after exercise

392

$32.00

$12.54K

GREY MICHAEL G

8 Jun 2023

Director

Sold after exercise

14,608

$29.00

$423.63K

GREY MICHAEL G

3 May 2023

Director

Sold after exercise

14,608

$28.00

$409.02K

Show all 214 transactions →

Mirum Pharmaceuticals, Inc.

By person

Individual transactions

What was left out